Uri Elia
Impact in
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research
-
- RNA Interference and Gene Delivery
- Bacillus and Francisella bacterial research
- vaccines and immunoinformatics approaches
Papers in
-
- SARS-CoV-2 and COVID-19 Research 9
-
- Bacillus and Francisella bacterial research 11
- RNA Interference and Gene Delivery 6
- Co-authors
- Dan Peer (9 shared papers)Edo Kon (4 shared papers)Ofer Cohen (23 shared papers)Erez Bar‐Haim (19 shared papers)Shahar Rotem (17 shared papers)Eliezer Flescher (2 shared papers)Theodor Chitlaru (16 shared papers)Gonna Somu Naidu (3 shared papers)
- Journals
- Vaccine (3 papers)American Journal of Tropical Medicine and Hygiene (2 papers)Scientific Reports (2 papers)Vaccines (2 papers)Molecular Therapy — Nucleic Acids (1 paper)
- Partner nations
- IsraelBelgiumUnited Kingdom
In The Last Decade
Uri Elia
34 papers receiving 718 citations
Peers
Comparison fields: 5 of 74
- Infectious Diseases 168
- Molecular Biology 379
- Immunology 89
- Biomaterials 52
- Microbiology 25
Countries citing papers authored by Uri Elia
This map shows the geographic impact of Uri Elia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uri Elia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uri Elia more than expected).
Fields of papers citing papers by Uri Elia
This network shows the impact of papers produced by Uri Elia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uri Elia. The network helps show where Uri Elia may publish in the future.
Co-authors
The 25 scholars most cited alongside Uri Elia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 227 | |
| 2 | 2021 | 90 | |
| 3 | 2023 | 78 | |
| 4 | 2022 | 37 | |
| 5 | 2008 | 33 | |
| 6 | 2021 | 28 | |
| 7 | 2022 | 24 | |
| 8 | 2016 | 20 | |
| 9 | 2019 | 18 | |
| 10 | 2012 | 17 | |
| 11 | 2017 | 15 | |
| 12 | 2019 | 14 | |
| 13 | 2022 | 14 | |
| 14 | 2017 | 12 | |
| 15 | 2022 | 12 | |
| 16 | 2013 | 11 | |
| 17 | 2019 | 9 | |
| 18 | 2019 | 8 | |
| 19 | 2022 | 7 | |
| 20 | 2023 | 7 |
About Uri Elia
Uri Elia is a scholar working on Infectious Diseases, Molecular Biology, Immunology, Epidemiology and Genetics, having authored 35 papers that have together received 729 indexed citations. Recurring topics across this work include Bacillus and Francisella bacterial research (11 papers), SARS-CoV-2 and COVID-19 Research (9 papers), RNA Interference and Gene Delivery (6 papers), Burkholderia infections and melioidosis (4 papers), Immunotherapy and Immune Responses (4 papers), Yersinia bacterium, plague, ectoparasites research (2 papers), Cancer, Hypoxia, and Metabolism (1 paper) and Bioactive Compounds and Antitumor Agents (1 paper). The work is most often cited by research in Infectious Diseases (168 citations), Molecular Biology (379 citations), Immunology (89 citations), Biomaterials (52 citations) and Microbiology (25 citations). Uri Elia has collaborated with scholars based in Israel, Belgium and United Kingdom. Frequent co-authors include Dan Peer, Edo Kon, Ofer Cohen, Erez Bar‐Haim, Shahar Rotem, Eliezer Flescher, Theodor Chitlaru, Gonna Somu Naidu, Ma’ayan Israeli and Moshe Aftalion. Their work appears in journals such as Vaccine, American Journal of Tropical Medicine and Hygiene, Scientific Reports, Vaccines and Molecular Therapy — Nucleic Acids.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.